Practical criteria for screening patients at high risk for diabetic foot ulceration

Archives of Internal Medicine

Volumn 158, Issue 2, 1998, Pages 157-162

  Lavery, Lawrence A ^a,b,c   Armstrong, David G ^a,b   Vela, Steven A ^a,b   Quebedeaux, Terri L ^a   Fleischli, John G ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Diabetic Foot Research Group   (United States)

^c Mex Amer Med Treatm E   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; DISEASE DURATION; FEMALE; FOOT MALFORMATION; FOOT ULCER; HIGH RISK PATIENT; HUMAN; LEG AMPUTATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SEX DIFFERENCE;

ADULT; AGED; CASE-CONTROL STUDIES; DIABETIC FOOT; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; RISK; RISK FACTORS;

EID: 0031965181     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.2.157     Document Type: Article

References (54)

1. Edelson GW, Armstrong DG, Lavery LA, Caicco G. The acutely infected diabetic foot is not adequately evaluated in an inpatient setting. Arch Intern Med. 1996; 156:2373-2376.
2. Pecoraro RE, Reiber GE, Burgess EM. Causal pathways to amputation: basis for prevention. Diabetes Care. 1990;13:513-521.
3. Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus: a case-control study. Ann Intern Med. 1992;117:97-105.
4. Apelqvist J, Ragnarson-Tennval G, Persson U, Larsson J. Diabetic foot ulcers in a multidisciplinary setting: an economic analysis of primary healing and healing with amputation. J Intern Med. 1994;235:463-471.
5. Levin ME. The diabetic foot: pathophysiology, evaluation, and treatment. In: Levin ME, O'Neal LW, eds. The Diabetic Foot. St Louis, Mo: Mosby-Yearbook Inc; 1988:7-27.
6. Tan JS, Flanagan PJ, Donovan DL, File TM. Team approach in the management of diabetic foot infections. J Foot Surg. 1987;(26suppl 1):S12-S16.
7. Edmonds ME. Experience in a multidisciplinary diabetic foot clinic. In: Connor H, Boulton AJM, Ward JD, eds. The Foot in Diabetes. Chichester, NY: John Wiley & Sons; 1987:121-131.
8. Reiber GE. Diabetic foot care: financial implications and practice guidelines. Diabetes Care. 1992;15:29-31.
9. Gibbons GW, Marcaccio EJ Jr, Burgess AM, et al. Improved quality of diabetic foot care, 1984 vs 1990: reduced length of stay and costs, insufficient reimbursement. Arch Surg. 1993;128:576-581.
10. Crausaz FM, Clavel S, Liniger C, Albenau A, Assal JP. Additional factors associated with plantar ulcers in diabetic neuropathy. Diabetic Med. 1988;5:771-775.
11. McNeely MJ, Boyko EJ, Ahroni JE, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. Diabetes Care. 1995;18:216-219.
12. Sriussadaporn S, Mekanandha P, Vannasaeng S, et al. Factors associated with diabetic foot ulceration in Thailand: a case-control study. Diabet Med. 1997;14:50-56.
13. Holewski J, Moss K, Stess R, Grunfeld C. Prevalence of foot pathology and lower extremity complications in a diabetic outpatient clinic. J Rehabil Res Dev. 1989;26:35-44.
14. Second Report on Diabetes Mellitus. Geneva, Switzerland: World Health Organization; 1980.
15. Harris MI. Classification, diagnostic criteria and screening for diabetes. In: Group NDD, ed. Diabetes in America, Bethesda, Md: US Dept of Health and Human Services; 1995. Publication NIH 95-1468.
16. Savage S, Estacio RO, Jetfers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care. 1996;19:1243-1248.
17. Humphrey LL, Ballard DJ, Frohnert PP, Chu CP, O'Fallon M, Palumbo PJ. Chronic renal failure in non-insulin-dependent diabetes mellitus. Ann Intern Med. 1989;111:788-796.
18. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK, Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia. 1995;38:437-444.
19. Swartz MH. The physical examination. In: Swartz MH, ed. Physical Diagnosis. Philadelphia, Pa: WB Saunders Co; 1989:73-82.
20. Young MJ, Breddy JL, Veves A, Boulton AJM. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. Diabetes Care. 1994;16:557-560.
21. Rose GA. Diagnosis of ischemic heart pain and intermittent claudication in field study. Bull World Health Organ. 1962;27:645-650.
22. Beach KW, Strandness DE. Arteriosclerosis obliterans and associated risk factors in insulin-dependent and non-insulin-dependent diabetes. Diabetes. 1980;29:882-888.
23. Magruder-Habib K, Stevens HA, Alling WC, Relative performance of the MAST, VAST, and CAGE versus DSM-III-R criteria for alcohol dependence. J Clin Epidemiol. 1993;46:435-441.
24. Birke J, Cornwall MA, Jackson M. Relationship between hallux limitus and ulceration of the great toe. Sports Phys Ther J Orthop. 1988;10:172-176.
25. Birke JA, Franks D, Foto JG. First ray joint limitation, pressure, and ulceration of the first metatarsal head in diabetes mellitus. Foot Ankle. 1995;16:277-284.
26. Hopson MM, McPoil TG, Cornwall NW, Motion of the first metatarsophalangeal joint: reliability and validity of four measurement techniques. J Am Podiatr Med Assoc. 1995;8:198-204.
27. Schlesselmann JJ. Case-Control Studies: Design, Conduct, Analysis. New York, NY: Oxford University Press; 1982:chap 2.
28. Walker SH, Duncan DB. Estimation of the probability of an event as a function of several independent variables. Biometrika. 1967;54:167-179.
29. Armstrong DG, Lavery LA, Harkless LB. Treatment-based classification system for assessment and care of diabetic feet. J Am Podiatr Med Assoc. 1996;86:311-316.
30. Birke JA, Sims DS. The insensitive foot. In: Hunt GC, McPoil TG, eds. Physical Therapy of the Foot and Ankle. 2nd ed. New York, NY: Churchill Livingstone Inc; 1995:chap3.
31. Hauser CJ, Klein SR, Mehringer CM, Appel P, Shoemaker WC. Assessment of perfusion in the diabetic foot by regional transcutaneous oximetry. Diabetes. 1984;33:527-531.
32. Kumar S, Fernando DJS, Veves A, Knowles EA, Young MJ, Boulton AJM, Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract. 1991;13:63-68.
33. Mueller MJ. Identifying patients with diabetes who are at risk for lower extremity complications: use of Semmes-Weinstein monofilaments. Phys Ther. 1996;76:68-71.
34. Brand PW. The insensitive foot (including leprosy). In: Jahss M, ed. Disorders of the Foot and Ankle. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1991:2170-2175.
35. Armstrong DG, Lavery LA, Bushman TR. Peak foot pressures influence healing time of diabetic ulcers treated with total contact casting. J Rehabil Res Dev. In press.
36. Lavery LA, Lavery DC, Quebedeaux TL. Increased foot pressures after great toe amputation in diabetes. Diabetes Care. 1995;18:1460-1462.
37. Strowig S, Raskin P. Glycemic control and diabetic complications. Diabetes Care. 1992;15:1126-1140.
38. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, et al. Effect of near nor-moglycemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo Study. BMJ. 1986;293:1195-1199.
39. Diabetes Control and Complications Trial Research Group. The effect of Intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:966-986.
40. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care. 1992;15:1835-1843.
41. Rosenbloom AL. Skeletal and joint manifestations of childhood diabetes. Pediatr Clin North Am. 1984;31:569-589.
42. Rosenbloom AL, Silverstein JH, Lexotte DC. Limited joint mobility in childhood diabetics indicates increased risk for microvascular diseases. N Engl J Med. 1982;305:191-194.
43. Moss SE, Klein R, Klein BEK. The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Intern Med. 1992;152:610-616.
44. Alcolado JC, Pacy PJ, Beevers M, Dodson PM. Risk factors for peripheral vascular disease in hypertensive subjects with type 2 diabetes mellitus. Diabet Med. 1992;9:904-907.
45. Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. J Clin Epidemiol. 1992;45:529-542.
46. Melton LJ, Macken KM, Palumbo PJ, Elveback LR. Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients. Diabetes Care. 1980;3:650-654.
47. Franklin GM, Kahn LB, Baxter J, Marshall JA. Sensory neuropathy in non-insulin dependent diabetes mellitus: The San Luis Valley Diabetes Study. Am J Epidemiol. 1990;131:633-643.
48. van Houtum WH, Lavery LA, Harkless LB. The impact of diabetes-related lower extremity amputations in the Netherlands. J Diabetes Complications. 1996;10:325-330.
49. Armstrong DG, Lavery LA, van Houtum WH, Harkless LB. The impact of gender on amputation. J Foot Ankle Surg. 1997;36:66-69.
50. Armstrong DG, Todd WF, Lavery LA, Harkless LB. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabet Med. 1997;14:357-363.
51. Rosset J, Walker EA, Shamoon H, Engel S, Basch C, Zybert P. Assessment of documented foot examinations for patients with diabetes in inner-city primary care clinics. Arch Fam Med. 1990;4:46-50.
52. Cohen SJ. Potential barriers to diabetes care. Diabetes Care. 1983;6:499-500.
53. Young MJ, Cavanagh PR, Thomas G, Johnson MN, Murray H. Effect of callous removal on dynamic foot pressures in diabetic patients. Diabet Med. 1992;9:75-77.
54. Eckman MH, Greenfield S, Mackey WC, et al. Foot infections in diabetic patients: decision and cost-effectiveness analysis. JAMA. 1995;273:712-720.